In conclusion, we identified GIPR signaling as an important regulator of type 2 immunity networks in epiWAT and energy expenditure in ingWAT and a gatekeeper of the unrestrained activity of S100A8/A9 in myeloid cells during obesity. This evidence concerns the gene IGKV1D-22 and Obesity.